Logo

Latest Press Releases

July 31, 2023
Neurona Therapeutics Appoints James Stutz as Chief Financial Officer and Chief Business Officer

June 15, 2023
Neurona Therapeutics Presents One-Year Data on the First Patient Treated with NRTX-1001 Cell Therapy in an Ongoing Phase I/II Trial for Drug-resistant Focal Epilepsy 

April 24, 2023
Neurona Therapeutics Presents Updated Data from the NRTX-1001 Cell Therapy Trial in Adults with Drug-resistant Focal Epilepsy at American Academy of Neurology (AAN) 2023 Annual Meeting

More Press Releases

photo of neuron

In the news

Click to play video of Interview with patient caregiver

Interview with patient caregiver at the XVII Conference on Epilepsy Therapies & Diagnostics Development (ETDD)
(with permission from ETDD, patient and caregiver)

September 2023
Promising Initial Clinical Data for Drug-Resistant Epilepsy

August 9, 2023
After 25 Years of Hype, Embryonic Stem Cells are Still Waiting for Their Moment

July 26, 2023
UC San Diego Health among First in Nation to Perform Regenerative Brain Cell Procedure for Epilepsy

More News Articles

Events

September 21, 2023
UBS Biotechnology Private Company Virtual Symposium

More Events

  • About
    • Mission / Vision
    • Leadership
    • Board of Directors
    • Scientific Advisors
    • Investors
  • Technology
    • Approach
    • Manufacturing
    • Publications
  • Pipeline
    • Programs
  • Clinical Trials
    • Phase I/II NRTX-1001 for epilepsy
    • Phase I/II NRTX-1001 for epilepsy on clinicaltrials.gov
  • News
    • Press Releases
      • 073123
      • 061523
      • 042423
      • 030823
      • 021423
      • 120522
      • 112122
      • 092122
      • 062922
      • 061722
      • 052622
      • 040422
      • 040122
      • 010522
      • 121321
      • 120321
      • 111821
      • 110821
      • 110421
      • 102022
      • 062221
      • 061621
      • 041921
      • 103119
      • 121417
      • 120117
    • In the News
    • Events
  • Careers
    • Culture
    • Values
    • Benefits
    • Visiting Scientists & Internship programs
    • Job Opportunities
  • Contact
  • Home
  • About
    • Mission / Vision
    • Leadership
    • Board of Directors
    • Scientific Advisors
    • Investors
  • Technology
    • Approach
    • Manufacturing
    • Publications
  • Pipeline
    • Programs
  • Clinical Trials
    • Phase I/II NRTX-1001 for epilepsy
    • Phase I/II NRTX-1001 for epilepsy on clinicaltrials.gov
  • News
    • Press Releases
      • 073123
      • 061523
      • 042423
      • 030823
      • 021423
      • 120522
      • 112122
      • 092122
      • 062922
      • 061722
      • 052622
      • 040422
      • 040122
      • 010522
      • 121321
      • 120321
      • 111821
      • 110821
      • 110421
      • 102022
      • 062221
      • 061621
      • 041921
      • 103119
      • 121417
      • 120117
    • In the News
    • Events
  • Careers
    • Culture
    • Values
    • Benefits
    • Visiting Scientists & Internship programs
    • Job Opportunities
  • Contact
Logo
Neurona Therapeutics
170 Harbor Way
South San Francisco, CA 94080
info@neuronatx.com
LinkedIn
© 2023 Neurona Therapeutics All rights reserved
  • Terms of Use
  • Privacy Policy
Website Design : Hane Chow, Inc.